Processes
发表于 2025-3-26 22:34:50
http://reply.papertrans.cn/29/2832/283170/283170_31.png
instill
发表于 2025-3-27 04:49:38
Deji Chen,Mark Nixon,Aloysius Moktibodies inhibiting osteoclastic activity, such as denosumab, and other antiangiogenic cancer drugs..Many risk factors have been identified: duration of the treatment, therapeutic indications, type of bisphosphonate, genetic factors, anatomic factors, dento-alveolar surgery, etc.
纠缠,缠绕
发表于 2025-3-27 06:25:26
http://reply.papertrans.cn/29/2832/283170/283170_33.png
壮丽的去
发表于 2025-3-27 13:24:34
http://reply.papertrans.cn/29/2832/283170/283170_34.png
esculent
发表于 2025-3-27 15:25:02
Drug-Induced Oral Mucosal Pigmentation,ation and chronic irritation. Different medications, amalgam and other metals may also induce pigmentary modifications in the oral mucosa..Proper diagnosis and treatment of oral pigmentations will help the general dentist manage patients presenting with such lesions.
osculate
发表于 2025-3-27 19:37:02
Drug-Induced Oral Lichenoid Reaction,duration of onset of lichenoid lesions varies widely, ranging from 2 weeks to a few months. These lesions generally regress with the suppression of the cause sometimes leaving cheloid type scars in the oral mucosa.
红润
发表于 2025-3-27 22:32:00
Medication-Related Osteonecrosis of the Jaws,tibodies inhibiting osteoclastic activity, such as denosumab, and other antiangiogenic cancer drugs..Many risk factors have been identified: duration of the treatment, therapeutic indications, type of bisphosphonate, genetic factors, anatomic factors, dento-alveolar surgery, etc.
杂役
发表于 2025-3-28 06:03:43
http://reply.papertrans.cn/29/2832/283170/283170_38.png
DIKE
发表于 2025-3-28 06:14:52
Book 2021reatments, focusing especially on recently developed therapies. Among the diverse adverse drug reactions covered are gingival overgrowth, ulcerations, lichenoid reactions, pigmentation, and bullous reactions. The potential direct toxic effects on bone of drugs that prevent bone mass loss, such as bi
Minikin
发表于 2025-3-28 11:03:29
http://reply.papertrans.cn/29/2832/283170/283170_40.png